Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/26533
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNiriella, M.A.
dc.contributor.authorEdiriweera, D.S.
dc.contributor.authorWithanage, M.Y.
dc.contributor.authorDarshika, S.
dc.contributor.authorde Silva, S.T.
dc.contributor.authorde Silva, H.J.
dc.date.accessioned2023-09-19T06:19:53Z
dc.date.available2023-09-19T06:19:53Z
dc.date.issued2023
dc.identifier.citationThe Lancet Regional Health - Southeast Asia.2023;100220en_US
dc.identifier.issn2772-3682 (Electronic)
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/26533
dc.descriptionNot Indexed in MEDLINE.en_US
dc.description.abstractBACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the commonest chronic liver disease worldwide. We estimated the prevalence and predefined associated factors for NAFLD among South-Asian adults. METHODS: We searched PubMed and included descriptive, epidemiological studies with satisfactory methodology, reporting the prevalence of NAFLD with ultrasound. Two authors screened and extracted data independently. Gender, urban/rural settings, general population and individuals with metabolic diseases (MetD) stratified the analysis. In addition, a random-effects meta-analysis of the prevalence and effect sizes of associations of NAFLD was performed. FINDINGS: Twenty-two publications were included after the quality assurance process. The difference in the NAFLD prevalence between the general population and people with MetD was found to be statistically significant (Q = 15.8, DF = 1, P < 0.001). The pooled overall prevalence of NAFLD in the general population was 26.9% (95% CI: 18.9-35.8%) with high heterogeneity. The prevalence was similar among men and women (Q = 0.06, DF = 1, P = 0.806). The NAFLD prevalence in the rural communities was 22.6% (95% CI: 13.6-33.1%), and the prevalence in urban communities was 32.9% (95% CI: 22.8-43.8%) and the difference was not statistically significant (Q = 1.92, DF = 1, P = 0.166). The pooled overall prevalence of NAFLD in patients with MetD was 54.1% (95% CI: 44.1-63.9%) with high heterogeneity. The pooled overall prevalence of NAFLD in the non-obese population was 11.7% (95% CI: 7.0-17.3%). The pooled prevalence of non-obese NAFLD in the NAFLD population was 43.4% (95% CI: 28.1-59.4%). Meta-analysis of binary variables showed that NAFLD in the South Asian population was associated with diabetes mellitus, hypertension, dyslipidaemia, general obesity, central obesity and metabolic syndrome. Gender was not associated with NAFLD. INTERPRETATION: The overall prevalence of NAFLD among adults in South Asia is high, especially in those with MetD, and a considerable proportion is non-obese. In the South Asian population, NAFLD was associated with diabetes mellitus, hypertension, dyslipidaemia, general obesity, central obesity, and metabolic syndrome.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectAssociationsen_US
dc.subjectMeta-analysisen_US
dc.subjectNAFLDen_US
dc.subjectNon-alcoholic fatty liver diseaseen_US
dc.subjectPooled prevalenceen_US
dc.subjectPrevalenceen_US
dc.subjectSouth Asia.en_US
dc.titlePrevalence and associated factors for non-alcoholic fatty liver disease among adults in the South Asian Region: a meta-analysisen_US
dc.typeArticleen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
File Description SizeFormat 
main (1).pdf2.42 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.